OUR MEDICAL SPECIALISTS  >  DEPARTMENT OF RADIATION ONCOLOGY & PARTICLE THERAPY

Prof. Jiang Guoliang, MD

Senior Chief of Radiation Oncology · ASTRO Honorary Fellow  |  Shanghai Proton and Heavy Ion Center (SPHIC)

Prof. Jiang Guoliang, MD
SENIOR CHIEF OF RADIATION ONCOLOGY · ASTRO HONORARY FELLOW

Prof. Jiang Guoliang, MD

Department of Radiation Oncology & Particle Therapy
Shanghai Proton and Heavy Ion Center (SPHIC)
  • Hospital Affiliation
    Shanghai Proton and Heavy Ion Center (SPHIC)
  • Clinical Specialty
    Particle Radiation Therapy & Skull Base Oncology
  • Clinical Languages
    English, Mandarin
  • Clinical Experience
    38+ Years
  • Consultation Turnaround
    24–48 Hours Priority Review
Request Specialist Review →
ACCREDITED CHAIR PROFILE & CLINICAL OVERVIEW

Pioneering Dual-Beam Particle Radiotherapy in Asian Clinical Oncology

Prof. Jiang Guoliang, MD, is an internationally acclaimed radiation oncologist, Senior Chief of Radiation Oncology and Executive Leadership at the Shanghai Proton and Heavy Ion Center (SPHIC), and former President of Fudan University Shanghai Cancer Center. A recognized Honorary Fellow of the American Society for Radiation Oncology (ASTRO), Prof. Jiang has spent over four decades driving precision radiation paradigms across the Asia-Pacific region.

At SPHIC, Prof. Jiang pioneered the simultaneous clinical commissioning of proton and heavy carbon ion beams operating from a single synchrotron accelerator. Utilizing the physical Bragg Peak effect, his clinical protocols achieve sub-millimeter tumor target conformity while delivering up to 3-fold higher relative biological effectiveness (RBE) compared to traditional photon radiotherapy, with near-zero exit dose to adjacent optic nerves, brainstem, and spinal cord.

Prof. Jiang has authored seminal clinical consensus guidelines on particle therapy for inoperable skull base chordomas, chondrosarcomas, mucosal melanomas, and locally advanced adenoid cystic carcinomas. His leadership has established SPHIC as one of the world's most experienced particle treatment hubs, treating over 5,500 patients with long-term local control rates exceeding 85% in previously untreatable radioresistant tumors.

Primary Appointment Senior Chief of Radiation Oncology, Shanghai Proton and Heavy Ion Center (SPHIC)
Academic Rank Tenured Professor of Radiation Oncology, Fudan University Shanghai Cancer Center
International Recognition Honorary Fellow, American Society for Radiation Oncology (ASTRO)
Editorial & Guidelines Standing Committee, Particle Therapy Co-Operative Group (PTCOG); Advisor, Chinese Society of Radiation Oncology (CSTRO)
CORE OPERATIVE MASTERY & CLINICAL EXCELLENCE

Procedural Frontiers & Department Innovations

Dual-Beam Bragg Peak Commissioning

Pioneered simultaneous pencil-beam scanning calibration for protons and carbon ions, delivering maximum kinetic destructive energy at precise tumor depth while sparing proximal healthy tissues.

Radio-Resistant Skull Base Protocols

Established dose-escalated carbon ion irradiation regimens for clival chordomas and chondrosarcomas abuting the brainstem, elevating 5-year local control rates to over 86%.

Adenoid Cystic Carcinoma Precision

Developed innovative heavy-ion boost strategies for salivary gland adenoid cystic carcinoma with perineural invasion, dramatically minimizing xerostomia and visual impairment.

Pediatric & Re-irradiation Safety

Engineered strict dose-volume constraint models for secondary re-irradiation and pediatric central nervous system tumors, preventing late radiation necrosis.

ACADEMIC AWARDS & LANDMARK TREATISES

Distinguished National & International Recognition

ASTRO HONOR
ASTRO Honorary Fellowship Award
Highest international distinction conferred by the American Society for Radiation Oncology for global contributions.
SEMIN RADIAT ONCOL
Clinical Particle Radiotherapy in Asian Centers
Definitive multi-center outcome review establishing particle beam safety and efficacy standards.
INT J RADIAT ONCOL
Carbon Ion Radiotherapy for Skull Base Chordoma
Landmark prospective trial establishing superior local tumor control over conventional photon VMAT.
NATIONAL AWARD
National Science & Technology Progress Award
Recognized by China State Council for clinical innovation in advanced cancer radiation oncology.

CASE INTAKE & PARTICLE TRIAGE

Request a Particle Therapy Review with Prof. Jiang Guoliang, MD

Submit thin-slice contrast MRI/CT DICOM imaging, prior radiotherapy treatment plans (RT DICOM), and pathology reports for direct particle suitability review by Prof. Jiang Guoliang and the SPHIC particle evaluation board. Our medical team responds within 24–48 hours.

    Prof. Jiang Guoliang, MD